Eficiency, feasibility of antiretroviral therapy in Africa demonstrated in IRD-coordinated surveys

Three-quarters of all people hit by HIV live in Sub-Saharan Africa. It is vital therefore that antiretroviral treatments, available and effective in industrialized countries, can be used for patients in Africa. Several enquiries, coordinated by the Institut de Recherche pour le Dveloppement (IRD) are bringing proof that such treatments are both effective and feasible in several African countries.

Two main types of argument are often voiced which hold back development and adoption of antiretroviral therapies in developing countries:

uncertainty surrounding their biomedical efficacy, given the diversity of the HIV strains existing in Africa, the strong spread of the disease and possible viral resistance to drugs ;

the difficult social and economic situations: the high cost of medicines and inadequate health systems in most of the countries concerned. Public and government campaigns are for that reason often based solely on preventive measures (supposedly more cost-effective), the possibility of using antiretroviral therapies disregarded, which in any case raises serious ethical problems.

The Barcelona Conference on Aids is being held from 7 to 12 July. Many IRD researchers and their Senegalese partners are giving papers (see abstracts further on). The French National Agency for Aids Research (Agence nationale de recherches sur le sida, ANRS) are running a press information point about access to antiretroviral therapy.

A Franco-Senegalese research team have published in the June 2002 issue of the journal AIDS the result obtained so far, 18 months into a pilot scheme being conducted in Senegal. The experiment is the first to lift doubts surrounding the effectiveness and tolerance of antiretroviral therapies in Africa. It uses now-standard tritherapy regimes. Dr Ibrahima Ndoye of the Senegal National Committee for Aids Control (Comit national de lutte contre le sida du Sngal ) and Prof Eric Delaporte of the French lnstitut de

Contact: H. Deval or B. Robert
Institut de Recherche Pour le Dveloppement

Page: 1 2 3

Related medicine news :

1. Human studies show feasibility of brain-machine interfaces
2. Study examines lessons learned at Africas first public antiretroviral treatment clinic
3. Archival virus still necessitates life-long antiretroviral therapy
4. Allocating antiretrovirals
5. Substantial survival increase after highly active antiretroviral therapy for HIV-1 infection
6. Alcohol consumption increases HIV disease progression of patients receiving antiretroviral therapy
7. Guidelines issued for metabolic complications related to HIV & antiretrovirals
8. UCLA AIDS Institute scientists show antiretroviral drugs can eradicate AIDS epidemic
9. Timely antiretroviral therapy essential for best prognosis in people with HIV-1 infection
10. Exposure to hepatitis C has no effect on antiretroviral treatment outcomes in HIV patients
11. Successful implementation of pilot study for HIV antiretroviral therapy in Uganda

Post Your Comments:

(Date:8/31/2020)... ... ... economic outlook continues to put financial strain on many of us, so it just makes ... monthly expenses and put more into savings, if possible. , “That’s a great way to ... in place in case something were to happen to you,” says Lee Duncan, CMO & ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... improve outcomes for patients with advanced heart failure, today announced that the company ... the amount of $555,358 from the National Heart, Lung, and Blood Institute of ...
(Date:8/28/2020)... , ... August 28, 2020 , ... ... one-year subscription to a customized Lighthouse Health & Wellness mobile app and web-portal. ... this project. Motorola Solutions Foundation awards grants each year to organizations, such as ...
(Date:8/28/2020)... ... August 28, 2020 , ... A July ... that obese individuals are at an increased risk of developing severe COVID-19 symptoms. ... catch COVID-19; however, because the same organ systems that the coronavirus attacks are ...
(Date:8/26/2020)... ... August 26, 2020 , ... Smile Brands ... Global Inclusion Online Forum, leading a session entitled, “A CEO Guide for Delivering ... this magnitude designed to bring together the world’s leading diversity and inclusion executives, ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... ... September 03, 2020 , ... In ... safely return to schools and classrooms across the United States, IntraLogic Solutions ... technology product line. TEMPE is a non-contact, wall-mounted scanning thermometer that rapidly checks ...
(Date:9/1/2020)... , ... September 01, 2020 , ... ... technologies, will host the Agilent Science and Technology Virtual Symposium 2020 (ASTVS ... symposium, Agilent will open a suite of Live webinars and Networking sessions, with ...
(Date:9/1/2020)... DETROIT (PRWEB) , ... September 01, 2020 , ... Breast ... Centers of Disease Control (CDC), About 3% of breast cancers (about 7,500 women per ... mutations in the BRCA1 and BRCA2 genes. Both genes are detectable in the ...
Breaking Medicine Technology:
Cached News: